marketcaparena
Search

    HWKN

    HAWKINS INC

    Company overview

    Market capitalization
    $2.67B
    Employees
    1,200
    Latest publication
    2026-09-29
    About HAWKINS INC

    Hawkins, Inc. operates as a water treatment and specialty ingredients company in the United States. The company operates through three segments: Water Treatment, Food and Health Sciences, and Industrial Solutions. The Water Treatment segment provides chemicals, filtration media and systems, equipment, services and solutions for potable water, municipal and industrial wastewater, industrial process water, non-residential swimming pool water, and agricultural water. This segment also sells and services equipment, including tanks, valves, and pumps. The Food and Health Sciences segment provide ingredient distribution, processing, and formulation solutions, such as base chemistry, acid-based reactions, minerals, vitamins and amino acids, excipients, botanicals and herbs, sweeteners and enzymes, fertilizers, and food-grade and pharmaceutical salts and ingredients to nutrition, food, pharmaceutical, and agricultural markets. The Industrial Solutions segment offers industrial chemicals, products, and services such as acids and alkalis, liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide to industrial manufacturing, chemical processing, electronics, energy, plating, and surface finishing industries. It also repackages water treatment chemicals and bulk industrial chemicals; and performs custom blending of chemicals. Hawkins, Inc. was founded in 1938 and is headquartered in Roseville, Minnesota.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20272026-06-28 · USDQ4 20262026-03-31 · USDQ3 20262025-12-31 · USDQ2 20262025-09-30 · USDQ1 20262025-06-30 · USDQ4 20252025-03-31 · USDQ3 20252024-12-31 · USDQ2 20252024-09-30 · USD
    Total Revenue315,675,000USD265,910,000USD244,080,000USD280,434,000USD293,272,000USD245,318,000USD226,205,000USD247,029,000USD
    Cost Of Revenue241,668,000USD211,673,000USD193,267,000USD212,791,000USD220,910,000USD196,634,000USD177,781,000USD186,807,000USD
    Gross Profit74,007,000USD54,237,000USD50,813,000USD67,643,000USD72,362,000USD48,684,000USD48,424,000USD60,222,000USD
    Selling General Administrative35,335,000USD30,773,000USD28,257,000USD33,703,000USD31,029,000USD27,662,000USD27,361,000USD26,477,000USD
    Total Operating Expenses35,335,000USD32,183,000USD31,976,000USD33,168,000USD32,612,000USD23,767,000USD27,018,000USD26,477,000USD
    Operating Income38,672,000USD22,054,000USD18,837,000USD34,475,000USD39,750,000USD24,917,000USD21,406,000USD33,745,000USD
    Total Other Income Expense Net-1,348,000USD-2,130,000USD744,000USD-3,646,000USD-744,000USD-2,495,000USD-1,123,000USD-754,000USD
    Net Interest Income-2,773,000USD-2,972,000USD-3,434,000USD-3,832,000USD-3,269,000USD-1,526,000USD-1,216,000USD-1,427,000USD
    Income Before Tax37,324,000USD19,924,000USD19,581,000USD30,829,000USD39,006,000USD22,422,000USD20,283,000USD32,991,000USD
    Income Tax Expense9,070,000USD4,461,000USD5,269,000USD8,231,000USD9,831,000USD6,095,000USD5,262,000USD8,873,000USD
    Net Income28,254,000USD15,463,000USD14,312,000USD22,598,000USD29,175,000USD16,327,000USD15,021,000USD24,118,000USD
    Unclassified Operating Expenses—1,410,000USD3,719,000USD—1,583,000USD-3,895,000USD——
    Interest Expense—2,972,000USD3,434,000USD3,832,000USD3,269,000USD1,526,000USD1,216,000USD1,427,000USD
    Tax Provision—4,461,000USD5,269,000USD8,231,000USD9,831,000USD6,095,000USD5,262,000USD8,873,000USD
    Net Income From Continuing Ops—15,463,000USD14,312,000USD22,598,000USD29,175,000USD16,327,000USD15,021,000USD24,118,000USD
    Ebit—22,896,000USD23,015,000USD34,661,000USD42,275,000USD23,948,000USD21,499,000USD34,418,000USD
    Ebitda—36,475,000USD36,425,000USD47,923,000USD54,566,000USD34,528,000USD31,611,000USD44,345,000USD
    Depreciation And Amortization—13,579,000USD13,410,000USD13,262,000USD12,291,000USD10,580,000USD10,112,000USD9,927,000USD
    Reconciled Depreciation—13,579,000USD13,410,000USD13,262,000USD12,291,000USD10,580,000USD10,112,000USD9,927,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-03-31 · USDFY 20252025-03-31 · USDFY 20242024-03-31 · USDFY 20232023-03-31 · USDFY 20222022-03-31 · USDFY 20212021-03-31 · USDFY 20202020-03-31 · USDFY 20192019-03-31 · USD
    Total Revenue1,083,696,000USD974,431,000USD919,162,000USD935,098,000USD774,541,000USD596,871,000USD540,198,000USD556,326,000USD
    Cost Of Revenue859,941,000USD761,693,000USD725,526,000USD769,979,000USD628,021,000USD473,109,000USD439,281,000USD460,390,000USD
    Gross Profit223,755,000USD212,738,000USD193,636,000USD165,119,000USD146,520,000USD123,762,000USD100,917,000USD95,936,000USD
    Selling General Administrative123,762,000USD106,364,000USD89,600,000USD76,969,000USD75,326,000USD67,884,000USD59,246,000USD59,118,000USD
    Unclassified Operating Expenses-15,123,000USD-14,169,000USD——————
    Total Operating Expenses108,639,000USD92,195,000USD89,600,000USD76,969,000USD75,326,000USD67,884,000USD59,246,000USD59,118,000USD
    Operating Income115,116,000USD120,543,000USD104,036,000USD88,150,000USD71,194,000USD55,878,000USD41,671,000USD36,818,000USD
    Interest Expense13,507,000USD5,432,000USD4,282,000USD5,234,000USD1,404,000USD1,467,000USD2,511,000USD3,361,000USD
    Net Interest Income-13,507,000USD-5,432,000USD-4,282,000USD-5,234,000USD-1,404,000USD-1,467,000USD-2,511,000USD-3,361,000USD
    Income Before Tax109,340,000USD114,383,000USD101,145,000USD82,582,000USD69,979,000USD55,851,000USD38,956,000USD33,530,000USD
    Income Tax Expense27,792,000USD30,038,000USD25,782,000USD22,541,000USD18,437,000USD14,871,000USD10,589,000USD9,097,000USD
    Tax Provision27,792,000USD30,038,000USD25,782,000USD22,541,000USD18,437,000USD14,871,000USD10,589,000USD9,097,000USD
    Net Income81,548,000USD84,345,000USD75,363,000USD60,041,000USD51,542,000USD40,980,000USD28,367,000USD24,433,000USD
    Net Income From Continuing Ops81,548,000USD84,345,000USD75,363,000USD60,041,000USD51,542,000USD40,980,000USD28,367,000USD24,433,000USD
    Ebit122,847,000USD119,815,000USD105,427,000USD87,816,000USD71,383,000USD55,878,000USD41,467,000USD36,891,000USD
    Ebitda175,389,000USD159,763,000USD137,230,000USD117,227,000USD95,512,000USD78,547,000USD63,051,000USD58,647,000USD
    Depreciation And Amortization52,542,000USD39,948,000USD31,803,000USD29,411,000USD24,129,000USD22,669,000USD21,584,000USD21,756,000USD
    Reconciled Depreciation52,542,000USD39,948,000USD31,803,000USD27,440,000USD24,129,000USD22,669,000USD21,584,000USD21,756,000USD
    Total Other Income Expense Net-5,776,000USD-6,160,000USD-2,891,000USD-5,568,000USD-1,215,000USD-27,000USD-2,715,000USD-3,288,000USD
    Non Operating Income Net Other———-334,000USD189,000USD1,440,000USD-204,000USD73,000USD
    Net Income Applicable To Common Shares———60,041,000USD51,542,000USD40,980,000USD28,367,000USD24,433,000USD
    Interest Income———————3,361,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20272026-06-28 · USDQ4 20262026-03-31 · USDQ3 20262025-12-31 · USDQ2 20262025-09-30 · USDQ1 20262025-06-30 · USDQ4 20252025-03-31 · USDQ3 20252024-12-31 · USDQ2 20252024-09-30 · USD
    Total Assets1,006,243,000USD1,001,696,000USD976,526,000USD984,164,000USD988,274,000USD769,867,000USD707,240,000USD689,697,000USD
    Cash And Equivalents7,977,000USD———————
    Total Current Assets248,779,000USD231,465,000USD228,203,000USD239,558,000USD256,423,000USD230,691,000USD210,355,000USD209,875,000USD
    Other Current Assets9,165,000USD8,665,000USD10,319,000USD5,148,000USD6,098,000USD7,417,000USD8,895,000USD5,563,000USD
    Other Non Current Assets1,474,000USD———————
    Total Liabilities458,039,000USD———————
    Total Current Liabilities109,614,000USD104,844,000USD97,155,000USD98,560,000USD110,934,000USD107,135,000USD84,254,000USD92,341,000USD
    Other Current Liabilities15,083,000USD———————
    Other Non Current Liabilities231,000USD———————
    Total Stockholder Equity548,204,000USD534,009,000USD518,906,000USD506,968,000USD484,572,000USD460,292,000USD456,981,000USD443,372,000USD
    Total Equity Including Noncontrolling Interest548,204,000USD———————
    Long Term Debt244,000,000USD244,000,000USD253,375,000USD268,328,000USD288,281,000USD138,906,000USD103,884,000USD93,862,000USD
    Net Receivables151,773,000USD140,687,000USD123,742,000USD131,090,000USD140,107,000USD134,659,000USD111,521,000USD115,221,000USD
    Inventory79,864,000USD78,199,000USD85,933,000USD92,905,000USD95,716,000USD83,512,000USD81,634,000USD81,565,000USD
    Property Plant Equipment Net286,667,000USD283,096,000USD270,582,000USD264,847,000USD256,547,000USD238,735,000USD233,539,000USD229,509,000USD
    Goodwill223,828,000USD———————
    Intangible Assets229,018,000USD232,887,000USD238,381,000USD241,077,000USD239,975,000USD150,121,000USD130,474,000USD123,886,000USD
    Accounts Payable62,845,000USD59,835,000USD46,384,000USD55,270,000USD62,792,000USD61,195,000USD39,891,000USD50,956,000USD
    Common Stock207,000USD208,000USD207,000USD207,000USD207,000USD207,000USD208,000USD208,000USD
    Retained Earnings524,425,000USD500,142,000USD488,652,000USD478,309,000USD459,680,000USD434,259,000USD421,682,000USD410,425,000USD
    Accumulated Other Comprehensive Income822,000USD981,000USD935,000USD1,191,000USD1,408,000USD1,732,000USD2,308,000USD1,679,000USD
    Total Liab—467,687,000USD457,620,000USD477,196,000USD503,702,000USD309,575,000USD250,259,000USD246,325,000USD
    Other Current Liab—40,429,000USD38,973,000USD32,260,000USD31,363,000USD33,127,000USD34,450,000USD29,188,000USD
    Capital Stock—208,000USD207,000USD207,000USD207,000USD207,000USD208,000USD208,000USD
    Good Will—223,042,000USD223,035,000USD222,145,000USD218,899,000USD135,409,000USD116,738,000USD111,566,000USD
    Cash—3,914,000USD8,209,000USD10,415,000USD14,502,000USD5,103,000USD8,305,000USD7,526,000USD
    Cash And Short Term Investments—3,914,000USD8,209,000USD10,415,000USD14,502,000USD5,103,000USD8,305,000USD7,526,000USD
    Current Deferred Revenue—1,580,000USD—————2,284,000USD
    Net Debt—257,543,000USD270,078,000USD282,839,000USD294,163,000USD157,536,000USD116,105,000USD105,936,000USD
    Short Term Debt—3,000,000USD9,812,000USD9,812,000USD9,812,000USD12,813,000USD9,913,000USD9,913,000USD
    Short Long Term Debt Total—261,457,000USD278,287,000USD293,254,000USD308,665,000USD162,639,000USD124,410,000USD113,462,000USD
    Property Plant Equipment Gross—506,502,000USD486,192,000USD473,293,000USD457,878,000USD434,402,000USD423,523,000USD414,151,000USD
    Common Stock Shares Outstanding—20,870,810shares20,843,980shares20,845,744shares20,810,562shares20,848,000shares20,875,000shares20,860,000shares
    Non Current Assets Total—770,231,000USD748,323,000USD744,606,000USD731,851,000USD539,176,000USD496,885,000USD479,822,000USD
    Non Current Liabilities Total—362,843,000USD360,465,000USD378,636,000USD392,768,000USD202,440,000USD166,005,000USD153,984,000USD
    Non Current Liabilities Other—46,257,000USD51,238,000USD54,846,000USD54,328,000USD13,971,000USD12,723,000USD12,155,000USD
    Non Currrent Assets Other—14,500,000USD16,325,000USD16,537,000USD14,501,000USD14,911,000USD16,134,000USD14,861,000USD
    Net Working Capital—126,621,000USD131,048,000USD140,998,000USD145,489,000USD123,556,000USD126,101,000USD117,534,000USD
    Unclassified Non Current Assets—16,706,000USD——————
    Unclassified Non Current Liabilities—72,586,000USD55,852,000USD55,462,000USD50,159,000USD49,563,000USD49,398,000USD47,967,000USD
    Unclassified Equity—32,470,000USD28,905,000USD27,054,000USD23,070,000USD23,887,000USD32,575,000USD30,852,000USD
    Short Long Term Debt——9,812,000USD9,812,000USD9,812,000USD9,913,000USD9,913,000USD9,913,000USD
    Unclassified Current Liabilities——-7,826,000USD-8,594,000USD-2,845,000USD-9,913,000USD-9,913,000USD-9,913,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-03-31 · USDFY 20252025-03-31 · USDFY 20242024-03-31 · USDFY 20232023-03-31 · USDFY 20222022-03-31 · USDFY 20212021-03-31 · USDFY 20202020-03-31 · USDFY 20192019-03-31 · USD
    Total Assets1,001,696,000USD769,867,000USD673,160,000USD602,360,000USD567,328,000USD481,442,000USD396,190,000USD385,599,000USD
    Intangible Assets232,887,000USD150,121,000USD116,626,000USD73,060,000USD80,193,000USD76,368,000USD60,653,000USD65,726,000USD
    Other Current Assets8,665,000USD7,417,000USD6,596,000USD6,448,999USD6,431,000USD5,367,000USD4,927,000USD5,762,000USD
    Total Liab467,687,000USD309,575,000USD267,134,000USD252,344,000USD264,727,000USD216,196,000USD162,706,000USD167,738,000USD
    Total Stockholder Equity534,009,000USD460,292,000USD406,026,000USD350,016,000USD302,601,000USD265,245,999USD233,484,000USD217,861,000USD
    Other Current Liab40,429,000USD33,127,000USD35,064,000USD23,924,000USD23,164,000USD21,655,000USD16,602,000USD16,175,000USD
    Common Stock208,000USD207,000USD208,000USD209,000USD209,000USD210,000USD526,000USD530,000USD
    Capital Stock208,000USD207,000USD208,000USD209,000USD209,000USD210,000USD526,000USD530,000USD
    Retained Earnings500,142,000USD434,259,000USD364,549,000USD302,424,000USD254,384,000USD213,898,000USD182,947,000USD164,405,000USD
    Good Will223,042,000USD135,409,000USD103,399,000USD77,401,000USD77,401,000USD70,720,000USD58,440,000USD58,440,000USD
    Cash3,914,000USD5,103,000USD7,153,000USD7,566,000USD3,496,000USD2,998,000USD4,277,000USD9,199,000USD
    Cash And Short Term Investments3,914,000USD5,103,000USD7,153,000USD7,566,000USD3,496,000USD2,998,000USD4,277,000USD9,199,000USD
    Total Current Assets231,465,000USD230,691,000USD202,826,000USD232,044,000USD227,738,000USD163,007,000USD131,031,000USD139,409,000USD
    Total Current Liabilities104,844,000USD107,135,000USD103,307,000USD90,871,000USD101,466,000USD70,462,000USD62,220,000USD55,396,000USD
    Current Deferred Revenue1,580,000USD—1,943,000USD20,608,000USD19,073,000USD18,048,000USD13,538,000USD12,483,000USD
    Net Debt257,543,000USD157,536,000USD101,108,000USD112,765,000USD132,861,000USD107,572,000USD64,553,000USD75,366,000USD
    Short Term Debt3,000,000USD12,813,000USD9,913,000USD9,913,000USD11,570,000USD11,494,000USD11,430,000USD9,907,000USD
    Short Long Term Debt Total261,457,000USD162,639,000USD108,261,000USD120,331,000USD136,357,000USD110,570,000USD68,830,000USD84,565,000USD
    Long Term Debt244,000,000USD138,906,000USD88,818,000USD101,731,000USD115,644,000USD88,845,000USD49,751,000USD74,658,000USD
    Net Receivables140,687,000USD134,659,000USD114,477,000USD129,252,000USD122,826,000USD90,778,000USD67,391,000USD64,492,999USD
    Inventory78,199,000USD83,512,000USD74,600,000USD88,777,000USD94,985,000USD63,864,000USD54,436,000USD60,482,000USD
    Accounts Payable59,835,000USD61,195,000USD56,387,000USD53,705,000USD66,693,000USD37,313,000USD34,129,000USD29,314,000USD
    Property Plant Equipment Net283,096,000USD238,735,000USD220,587,000USD196,002,000USD172,452,000USD156,242,000USD135,434,000USD118,628,000USD
    Property Plant Equipment Gross506,502,000USD434,402,000USD398,361,000USD185,803,000USD161,846,000USD156,242,000USD135,434,000USD118,628,000USD
    Accumulated Other Comprehensive Income981,000USD1,732,000USD3,115,000USD2,940,000USD1,291,000USD-155,792,000USD-79,000USD317,000USD
    Common Stock Shares Outstanding20,861,860shares20,937,000shares21,014,326shares21,014,905shares21,135,258shares21,260,296shares21,308,800shares21,452,352shares
    Non Current Assets Total770,231,000USD539,176,000USD470,333,999USD370,316,000USD339,590,000USD318,435,000USD265,159,000USD246,190,000USD
    Non Current Liabilities Total362,843,000USD202,440,000USD163,827,000USD161,473,000USD163,261,000USD145,733,999USD100,485,999USD112,342,000USD
    Non Current Liabilities Other46,257,000USD13,971,000USD12,545,000USD8,687,000USD9,143,000USD1,368,000USD18,767,000USD11,011,000USD
    Non Currrent Assets Other14,500,000USD12,511,000USD10,195,999USD8,028,000USD9,544,000USD6,213,000USD3,770,000USD-1,203,000USD
    Net Working Capital126,621,000USD123,556,000USD99,519,000USD141,173,000USD126,272,000USD92,545,000USD68,811,000USD84,013,000USD
    Unclassified Non Current Assets16,706,000USD—19,526,000USD15,825,000USD-7,775,000USD—3,092,000USD—
    Unclassified Non Current Liabilities72,586,000USD49,563,000USD62,464,000USD27,255,000USD-23,422,000USD-6,690,001USD-29,362,001USD-37,684,000USD
    Unclassified Equity32,470,000USD23,887,000USD37,946,000USD44,234,000USD46,508,000USD206,719,999USD49,564,000USD52,079,000USD
    Short Long Term Debt—9,913,000USD9,913,000USD9,913,000USD9,913,000USD9,907,000USD9,907,000USD9,907,000USD
    Unclassified Current Liabilities—-9,913,000USD-9,913,000USD-27,192,000USD-28,947,000USD-27,955,000USD-23,386,000USD-22,390,000USD
    Other Assets——-15,226,000USD—7,775,000USD6,213,000USD3,770,000USD2,961,000USD
    Short Term Investments——32,000USD—————
    Deferred Long Term Liab———23,800,000USD23,422,000USD24,445,000USD25,106,000USD26,673,000USD
    Net Tangible Assets———350,016,000USD302,601,000USD118,158,000USD233,484,000USD217,861,000USD
    Other Liab————38,474,000USD37,766,000USD36,224,000USD37,684,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20272026-06-28 · USDQ4 20262026-03-31 · USDQ3 20262025-12-31 · USDQ2 20262025-09-30 · USDQ1 20262025-06-30 · USDQ4 20252025-03-31 · USDQ3 20252024-12-31 · USDQ2 20252024-09-30 · USD
    Net Income28,254,000USD15,463,000USD14,312,000USD22,598,000USD29,175,000USD16,327,000USD15,021,000USD24,118,000USD
    Depreciation13,945,000USD13,579,000USD13,410,000USD13,262,000USD12,291,000USD10,580,000USD10,112,000USD9,927,000USD
    Stock Based Compensation2,235,000USD6,819,000USD1,851,000USD2,375,000USD2,212,000USD1,476,000USD1,723,000USD1,832,000USD
    Unclassified Operating Cash Flow-6,593,000USD3,053,000USD——————
    Change To Account Receivables-12,462,000USD-15,278,000USD7,671,000USD7,791,000USD-2,651,000USD-17,387,000USD5,541,000USD11,192,000USD
    Change To Inventory-1,474,000USD7,734,000USD7,515,000USD3,291,000USD-8,487,000USD-890,000USD721,000USD-366,000USD
    Change To Liabilities-4,230,000USD———————
    Change In Working Capital-2,689,000USD3,274,000USD9,168,000USD502,000USD-10,561,000USD83,000USD-6,706,000USD5,227,000USD
    Operating Cash Flow35,152,000USD———————
    Capital Expenditures-11,605,000USD-19,576,000USD-14,321,000USD-10,798,000USD-13,544,000USD-11,088,000USD-8,722,000USD-10,637,000USD
    Other Investing Activities-3,860,000USD———————
    Unclassified Investing Cash Flow520,000USD1,248,000USD-4,600,000USD10,088,000USD13,217,000USD11,130,000USD8,493,000USD10,525,000USD
    Investing Cash Flow-14,945,000USD———————
    Net Common Stock Issuance-5,143,000USD———————
    Common Dividends Paid-3,971,000USD———————
    Other Financing Activities-9,000USD———————
    Unclassified Financing Cash Flow-7,021,000USD23,028,000USD—20,000,000USD—1,361,000USD-19,149,000USD2,673,000USD
    Financing Cash Flow-16,144,000USD———————
    Change In Cash4,063,000USD-4,295,000USD-2,206,000USD-4,087,000USD9,399,000USD-3,202,000USD779,000USD-1,361,000USD
    End Cash Flow7,977,000USD———————
    Other Non Cash Items—-4,453,000USD-3,180,000USD804,000USD-1,627,000USD2,378,000USD886,000USD526,000USD
    Total Cash From Operating Activities—37,735,000USD35,561,000USD39,541,000USD31,490,000USD30,844,000USD21,036,000USD41,630,000USD
    Free Cash Flow—18,159,000USD21,240,000USD28,743,000USD17,946,000USD19,756,000USD12,314,000USD30,993,000USD
    Total Cashflows From Investing Activities—-19,488,000USD-18,798,000USD-21,268,000USD-164,545,000USD-55,130,000USD-26,493,000USD-10,525,000USD
    Net Borrowings—-20,000,000USD-15,000,000USD-20,000,000USD150,000,000USD35,000,000USD10,000,000USD-30,000,000USD
    Total Cash From Financing Activities—-22,542,000USD-18,969,000USD-22,360,000USD142,454,000USD21,084,000USD6,236,000USD-32,466,000USD
    Dividends Paid—-3,973,000USD-3,969,000USD-3,969,000USD-3,754,000USD-3,750,000USD-3,764,000USD-3,763,000USD
    Sale Purchase Of Stock—-3,028,000USD0USD0USD-3,028,000USD-14,068,000USD9,149,000USD9,149,000USD
    Issuance Of Capital Stock—1,431,000USD0USD——1,361,000USD0USD1,297,000USD
    Begin Period Cash Flow—8,209,000USD10,415,000USD14,502,000USD5,103,000USD8,305,000USD7,526,000USD8,887,000USD
    End Period Cash Flow—3,914,000USD8,209,000USD10,415,000USD14,502,000USD5,103,000USD8,305,000USD7,526,000USD
    Other Cashflows From Investing Activities—-1,160,000USD123,000USD710,000USD327,000USD-42,000USD229,000USD112,000USD
    Other Cashflows From Financing Activities—-18,569,000USD—-18,391,000USD-764,000USD2,541,000USD10,000,000USD-10,525,000USD
    Investments———-21,268,000USD-164,545,000USD-55,130,000USD-26,493,000USD-10,525,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-03-31 · USDFY 20252025-03-31 · USDFY 20242024-03-31 · USDFY 20232023-03-31 · USDFY 20222022-03-31 · USDFY 20212021-03-31 · USDFY 20202020-03-31 · USDFY 20192019-03-31 · USD
    Net Income81,548,000USD84,345,000USD75,363,000USD60,041,000USD51,542,000USD40,980,000USD28,367,000USD24,433,000USD
    Depreciation52,542,000USD39,948,000USD31,803,000USD27,440,000USD24,129,000USD22,669,000USD21,584,000USD21,756,000USD
    Stock Based Compensation-1,554,000USD6,498,000USD4,880,000USD3,825,000USD3,818,000USD3,343,000USD2,273,000USD2,010,000USD
    Other Non Cash Items6,355,000USD4,229,000USD1,890,000USD-558,000USD2,255,000USD659,000USD2,922,000USD464,000USD
    Change To Account Receivables-2,467,000USD-11,230,000USD21,399,000USD-6,389,000USD-30,526,000USD-21,323,000USD-3,387,000USD-487,000USD
    Change To Inventory10,053,000USD-6,572,000USD19,921,000USD4,717,000USD-30,034,000USD-7,960,000USD6,045,000USD-746,000USD
    Change In Working Capital2,383,000USD-24,385,000USD47,022,000USD-13,116,000USD-37,406,000USD-23,169,000USD5,177,000USD-66,000USD
    Total Cash From Operating Activities144,327,000USD111,096,000USD159,499,000USD77,400,000USD42,837,000USD43,793,000USD58,902,000USD47,990,000USD
    Capital Expenditures-58,239,000USD-41,096,000USD-40,151,000USD-48,321,000USD-28,512,000USD-20,794,000USD-24,549,000USD-12,618,000USD
    Free Cash Flow86,088,000USD70,000,000USD119,348,000USD29,079,000USD14,325,000USD22,999,000USD34,353,000USD35,372,000USD
    Total Cashflows From Investing Activities-224,099,000USD-127,952,000USD-122,504,000USD-41,230,000USD-49,756,000USD-71,432,000USD-24,203,000USD-12,343,000USD
    Net Borrowings95,000,000USD50,000,000USD-13,000,000USD-14,000,000USD26,713,000USD39,000,000USD-25,000,000USD-16,183,000USD
    Total Cash From Financing Activities78,583,000USD14,806,000USD-37,408,000USD-32,100,000USD7,417,000USD26,360,000USD-39,621,000USD-31,438,000USD
    Dividends Paid-15,665,000USD-14,635,000USD-13,238,000USD-12,001,000USD-11,056,000USD-10,029,000USD-9,825,000USD-11,975,000USD
    Sale Purchase Of Stock-3,028,000USD-23,217,000USD-13,412,000USD-8,107,000USD-10,012,000USD-4,194,000USD-6,196,000USD-4,618,000USD
    Issuance Of Capital Stock3,040,000USD2,658,000USD2,242,000USD2,008,000USD1,772,000USD1,583,000USD1,400,000USD1,338,000USD
    Change In Cash-1,189,000USD-2,050,000USD-413,000USD4,070,000USD498,000USD-1,279,000USD-4,922,000USD4,209,000USD
    Begin Period Cash Flow5,103,000USD7,153,000USD7,566,000USD3,496,000USD2,998,000USD4,277,000USD9,199,000USD4,990,000USD
    End Period Cash Flow3,914,000USD5,103,000USD7,153,000USD7,566,000USD3,496,000USD2,998,000USD4,277,000USD9,199,000USD
    Other Cashflows From Investing Activities1,248,000USD544,000USD1,102,000USD7,091,000USD-21,244,000USD362,000USD346,000USD275,000USD
    Other Cashflows From Financing Activities-3,028,000USD29,441,000USD-2,140,000USD45,000,000USD41,713,000USD76,000,000USD19,000,000USD-183,000USD
    Unclassified Operating Cash Flow3,053,000USD———-1,501,000USD—-1,421,000USD—
    Unclassified Investing Cash Flow-167,108,000USD40,552,000USD39,049,000USD41,230,000USD49,756,000USD20,432,000USD24,203,000USD12,343,000USD
    Unclassified Financing Cash Flow5,304,000USD-26,783,000USD4,382,000USD-42,992,000USD-39,941,000USD-74,417,000USD-17,600,000USD1,521,000USD
    Investments—-127,952,000USD-122,504,000USD-41,230,000USD-49,756,000USD-71,432,000USD-24,203,000USD-12,343,000USD
    Change To Liabilities———-9,043,000USD28,075,000USD2,551,000USD5,477,000USD2,731,000USD
    Cash And Cash Equivalents Changes———4,070,000USD498,000USD-1,279,000USD-4,922,000USD4,209,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2027Quarterly · 2026-06-28ProductAgricultural27,914,000USDDisclosure
    Q1 2027Quarterly · 2026-06-28ProductBulk Products28,898,000USDDisclosure
    Q1 2027Quarterly · 2026-06-28ProductFood24,310,000USDDisclosure
    Q1 2027Quarterly · 2026-06-28ProductManufactured Blended Or Repackaged Products185,897,000USDDisclosure
    Q1 2027Quarterly · 2026-06-28ProductNutrition37,057,000USDDisclosure
    Q1 2027Quarterly · 2026-06-28ProductOther4,634,000USDDisclosure
    Q1 2027Quarterly · 2026-06-28ProductPharmaceutical6,965,000USDDisclosure
    Q1 2027Quarterly · 2026-06-28SegmentFood Health Sciences97,250,000USDDisclosure
    Q1 2027Quarterly · 2026-06-28SegmentIndustrial Solutions60,132,000USDDisclosure
    Q1 2027Quarterly · 2026-06-28SegmentWater Treatment158,293,000USDDisclosure
    FY 2026Yearly · 2026-03-31ProductAgricultural52,565,000USD0000046250-26-000018
    FY 2026Yearly · 2026-03-31ProductBulk96,154,000USD0000046250-26-000018
    FY 2026Yearly · 2026-03-31ProductFood99,278,000USD0000046250-26-000018
    FY 2026Yearly · 2026-03-31ProductManufacturedblendedorrepackagedproducts656,330,000USD0000046250-26-000018
    FY 2026Yearly · 2026-03-31ProductNutrition137,986,000USD0000046250-26-000018
    FY 2026Yearly · 2026-03-31ProductOther13,512,000USD0000046250-26-000018
    FY 2026Yearly · 2026-03-31ProductPharmaceutical27,871,000USD0000046250-26-000018
    FY 2026Yearly · 2026-03-31SegmentFood And Health Sciences320,700,000USD0000046250-26-000018
    FY 2026Yearly · 2026-03-31SegmentIndustrial Solutions219,693,000USD0000046250-26-000018
    FY 2026Yearly · 2026-03-31SegmentWater Treatment543,303,000USD0000046250-26-000018
    Q3 2026Quarterly · 2025-12-31ProductAgricultural8,362,000USD0000046250-26-000005
    Q3 2026Quarterly · 2025-12-31ProductBulk Products23,281,000USD0000046250-26-000005
    Q3 2026Quarterly · 2025-12-31ProductFood29,158,000USD0000046250-26-000005
    Q3 2026Quarterly · 2025-12-31ProductManufactured Blended Or Repackaged Products147,964,000USD0000046250-26-000005
    Q3 2026Quarterly · 2025-12-31ProductNutrition24,579,000USD0000046250-26-000005
    Q3 2026Quarterly · 2025-12-31ProductOther3,414,000USD0000046250-26-000005
    Q3 2026Quarterly · 2025-12-31ProductPharmaceutical7,322,000USD0000046250-26-000005
    Q3 2026Quarterly · 2025-12-31SegmentFood Health Sciences70,004,000USD0000046250-26-000005
    Q3 2026Quarterly · 2025-12-31SegmentIndustrial Solutions53,589,000USD0000046250-26-000005
    Q3 2026Quarterly · 2025-12-31SegmentWater Treatment120,487,000USD0000046250-26-000005
    Q2 2026Quarterly · 2025-09-30ProductAgricultural7,662,000USD0000046250-25-000057
    Q2 2026Quarterly · 2025-09-30ProductBulk Products24,028,000USD0000046250-25-000057
    Q2 2026Quarterly · 2025-09-30ProductFood24,548,000USD0000046250-25-000057
    Q2 2026Quarterly · 2025-09-30ProductManufactured Blended Or Repackaged Products180,983,000USD0000046250-25-000057
    Q2 2026Quarterly · 2025-09-30ProductNutrition33,412,000USD0000046250-25-000057
    Q2 2026Quarterly · 2025-09-30ProductOther3,131,000USD0000046250-25-000057
    Q2 2026Quarterly · 2025-09-30ProductPharmaceutical6,670,000USD0000046250-25-000057
    Q2 2026Quarterly · 2025-09-30SegmentFood Health Sciences72,914,000USD0000046250-25-000057
    Q2 2026Quarterly · 2025-09-30SegmentIndustrial Solutions56,612,000USD0000046250-25-000057
    Q2 2026Quarterly · 2025-09-30SegmentWater Treatment150,908,000USD0000046250-25-000057
    Q1 2026Quarterly · 2025-06-30ProductAgricultural21,469,000USD0000046250-25-000042
    Q1 2026Quarterly · 2025-06-30ProductBulk Products23,813,000USD0000046250-25-000042
    Q1 2026Quarterly · 2025-06-30ProductFood26,077,000USD0000046250-25-000042
    Q1 2026Quarterly · 2025-06-30ProductManufactured Blended Or Repackaged Products177,665,000USD0000046250-25-000042
    Q1 2026Quarterly · 2025-06-30ProductNutrition35,337,000USD0000046250-25-000042
    Q1 2026Quarterly · 2025-06-30ProductOther3,354,000USD0000046250-25-000042
    Q1 2026Quarterly · 2025-06-30ProductPharmaceutical5,557,000USD0000046250-25-000042
    Q1 2026Quarterly · 2025-06-30SegmentFood Health Sciences89,177,000USD0000046250-25-000042
    Q1 2026Quarterly · 2025-06-30SegmentIndustrial Solutions54,529,000USD0000046250-25-000042
    Q1 2026Quarterly · 2025-06-30SegmentWater Treatment149,566,000USD0000046250-25-000042
    Q4 2025Quarterly · 2025-03-31SegmentHealthand Nutrition42,933,000USDLegacy provider
    Q4 2025Quarterly · 2025-03-31SegmentIndustrial97,352,000USDLegacy provider
    Q4 2025Quarterly · 2025-03-31SegmentWater Treatment105,033,000USDLegacy provider
    FY 2025Yearly · 2025-03-31ProductAgricultural45,727,000USD0000046250-26-000018
    FY 2025Yearly · 2025-03-31ProductBulk87,862,000USD0000046250-26-000018
    FY 2025Yearly · 2025-03-31ProductFood103,403,000USD0000046250-26-000018
    FY 2025Yearly · 2025-03-31ProductManufacturedblendedorrepackagedproducts552,936,000USD0000046250-26-000018
    FY 2025Yearly · 2025-03-31ProductNutrition144,434,000USD0000046250-26-000018
    FY 2025Yearly · 2025-03-31ProductOther14,205,000USD0000046250-26-000018
    FY 2025Yearly · 2025-03-31ProductPharmaceutical25,864,000USD0000046250-26-000018
    FY 2025Yearly · 2025-03-31SegmentFood And Health Sciences322,560,000USD0000046250-26-000018
    FY 2025Yearly · 2025-03-31SegmentIndustrial Solutions205,382,000USD0000046250-26-000018
    FY 2025Yearly · 2025-03-31SegmentWater Treatment446,489,000USD0000046250-26-000018
    Q3 2025Quarterly · 2024-12-31ProductAgricultural9,834,000USD0000046250-26-000005
    Q3 2025Quarterly · 2024-12-31ProductBulk Products21,236,000USD0000046250-26-000005
    Q3 2025Quarterly · 2024-12-31ProductFood34,365,000USD0000046250-26-000005
    Q3 2025Quarterly · 2024-12-31ProductManufactured Blended Or Repackaged Products124,939,000USD0000046250-26-000005
    Q3 2025Quarterly · 2024-12-31ProductNutrition25,993,000USD0000046250-26-000005
    Q3 2025Quarterly · 2024-12-31ProductOther2,974,000USD0000046250-26-000005
    Q3 2025Quarterly · 2024-12-31ProductPharmaceutical6,864,000USD0000046250-26-000005
    Q3 2025Quarterly · 2024-12-31SegmentFood Health Sciences77,730,000USD0000046250-26-000005
    Q3 2025Quarterly · 2024-12-31SegmentIndustrial Solutions48,723,000USD0000046250-26-000005
    Q3 2025Quarterly · 2024-12-31SegmentWater Treatment99,752,000USD0000046250-26-000005
    Q2 2025Quarterly · 2024-09-30ProductAgricultural6,306,000USD0000046250-25-000057
    Q2 2025Quarterly · 2024-09-30ProductBulk Products20,853,000USD0000046250-25-000057
    Q2 2025Quarterly · 2024-09-30ProductFood25,902,000USD0000046250-25-000057
    Q2 2025Quarterly · 2024-09-30ProductManufactured Blended Or Repackaged Products152,295,000USD0000046250-25-000057
    Q2 2025Quarterly · 2024-09-30ProductNutrition32,447,000USD0000046250-25-000057
    Q2 2025Quarterly · 2024-09-30ProductOther3,131,000USD0000046250-25-000057
    Q2 2025Quarterly · 2024-09-30ProductPharmaceutical6,095,000USD0000046250-25-000057
    Q2 2025Quarterly · 2024-09-30SegmentFood Health Sciences71,402,000USD0000046250-25-000057
    Q2 2025Quarterly · 2024-09-30SegmentIndustrial Solutions51,099,000USD0000046250-25-000057
    Q2 2025Quarterly · 2024-09-30SegmentWater Treatment124,528,000USD0000046250-25-000057
    Q1 2025Quarterly · 2024-06-30ProductAgricultural16,994,000USD0000046250-25-000042
    Q1 2025Quarterly · 2024-06-30ProductBulk Products22,592,000USD0000046250-25-000042
    Q1 2025Quarterly · 2024-06-30ProductFood26,516,000USD0000046250-25-000042
    Q1 2025Quarterly · 2024-06-30ProductManufactured Blended Or Repackaged Products145,355,000USD0000046250-25-000042
    Q1 2025Quarterly · 2024-06-30ProductNutrition35,325,000USD0000046250-25-000042
    Q1 2025Quarterly · 2024-06-30ProductOther3,424,000USD0000046250-25-000042
    Q1 2025Quarterly · 2024-06-30ProductPharmaceutical5,673,000USD0000046250-25-000042
    Q1 2025Quarterly · 2024-06-30SegmentFood Health Sciences85,093,000USD0000046250-25-000042
    Q1 2025Quarterly · 2024-06-30SegmentIndustrial Solutions53,610,000USD0000046250-25-000042
    Q1 2025Quarterly · 2024-06-30SegmentWater Treatment117,176,000USD0000046250-25-000042
    FY 2024Yearly · 2024-03-31ProductAgricultural51,456,000USD0000046250-26-000018
    FY 2024Yearly · 2024-03-31ProductBulk83,081,000USD0000046250-26-000018
    FY 2024Yearly · 2024-03-31ProductFood114,516,000USD0000046250-26-000018
    FY 2024Yearly · 2024-03-31ProductManufacturedblendedorrepackagedproducts490,843,000USD0000046250-26-000018
    FY 2024Yearly · 2024-03-31ProductNutrition145,460,000USD0000046250-26-000018
    FY 2024Yearly · 2024-03-31ProductOther13,260,000USD0000046250-26-000018
    FY 2024Yearly · 2024-03-31ProductPharmaceutical20,546,000USD0000046250-26-000018

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.